Skip to main content
. 2009 Feb 19;64A(5):581–589. doi: 10.1093/gerona/glp005

Table 3.

Participant Characteristics by Inflammatory Component Level: TNF-Related Component and CRP-Related Component (N = 1,269*)

Variable Quartile 1 Quartile 2 Quartile 3 Quartile 4 P for Trend
TNF-α-related component
    Age (y) 73.0 ± 2.9 73.5 ± 2.7 73.8 ± 2.9 74.1 ± 2.9 <.001
    Black (%) 65.1 43.7 30.8 25.2 <.001
    Female (%) 58.8 53.5 45.6 47.3 .001
    Physical activity (kcal/wk) 842 ± 1,431 1,074 ± 1,822 1,131 ± 1,989 1,045 ± 2,062 .781
    Smoking (%)
        Never 49.4 45.4 41.8 40.4
        Current 12.6 9.5 9.4 10.7 .857
        Former 38.1 45.1 48.7 48.9 .005
    Alcohol use (%)
        None in past year 50.6 47.8 49.5 58.5
        Less than once/wk 22.3 19.6 19.2 17.1 .049
        Once to –seven times/week 18.6 26.6 25.2 15.5 .130
        More than seven times/wk 8.5 6.0 6.0 8.9 .725
    Prevalent clinical pulmonary disease (%) 10.4 10.5 14.5 15.2 .019
    Prevalent heart disease (%) 21.8 29.1 35.3 31.2 .003
    Prevalent diabetes (%)
        Not impaired 61.3 60.8 65.5 58.9
        Impaired fasting glucose 17.7 19.9 16.8 16.6 .620
        Diabetic fasting glucose 4.8 5.6 2.5 2.2 .037
        Known diabetic 16.1 13.7 15.2 22.3 .079
    Anti-inflammatory drug use (%) 49.7 57.8 62.6 56.8 .035
    Total lean mass (kg) 46.4 ± 10.3 46.7 ± 10.1 47.5 ± 9.7 46.8 ± 9.8 .4213
    Total fat mass (kg) 26.6 ± 8.8 27.2 ± 9.2 27.4 ± 8.8 27.5 ± 8.8 .2307
    Knee strength (Nm/kg) 108.8 ± 42.8 106.1 ± 42.8 107.2 ± 37.7 102.5 ± 35.8 .098
    400-m walk time 332.9 ± 59.9 328.8 ± 63.6 328.5 ± 71.6 335.8 ± 58.2 .661
    Walking speed for 20 m 1.30 ± 0.25 1.35± 0.27 1.34 ± 0.25 1.33 ± 0.25 .210
    HPPB 2.20 ± 0.51 2.17 ± 0.56 2.17 ± 0.57 2.08 ± 0.65 .014
    Grip strength 30.3 ± 10.5 29.6 ± 10.0 30.1 ± 10.4 29.0 ± 9.8 .211
CRP-related component
    Age (y) 73.7 ± 2.8 73.8 ± 2.9 73.6 ± 2.9 73.4 ± 2.9 .158
    Black (%) 29.7 36.5 41.3 57.4 <.001
    Female (%) 47.3 49.4 51.7 56.8 .014
    Physical activity (kcal/wk) 1,305 ± 2,064 997 ± 1,712 918 ± 1,621 872 ± 1,922 <.001
    Smoking (%)
        Never 47.3 51.3 42.6 35.8
        Current 8.2 8.5 9.5 16.1 <.001
        Former 44.5 40.3 48.0 48.1 .009
    Alcohol use (%)
        None in past year 48.4 49.4 54.8 53.9
        Less than once/wk 19.6 23.6 18.4 16.7 .088
        Once to seven times/wk 25.0 22.3 19.9 18.6 .027
        More than seven times/wk 7.0 4.7 7.0 10.7 .151
    Prevalent clinical pulmonary disease 7.9 9.8 16.5 16.5 <.001
    Prevalent heart disease 20.4 28.4 32.1 36.6 <.001
    Prevalent diabetes (%)
        Not impaired 74.4 67.1 54.7 50.3
        Impaired fasting glucose 12.8 17.9 19.7 20.5 <.001
        Diabetic fasting glucose 1.3 1.9 5.2 6.7 <.001
        Known diabetic 11.5 13.1 20.4 22.4 <.001
    Anti-inflammatory drug use (%) 56.7 56.6 56.2 57.4 .879
    Total lean mass (kg) 45.5 ± 9.9 46.8 ± 10.5 47.0 ± 9.6 48.1 ± 9.6 .0012
    Total fat mass (kg) 22.9 ± 6.7 26.8 ± 8.2 27.6 ± 8.1 31.4 ± 10.2 <.0001
    Knee strength (Nm/kg) 108.1 ± 39.8 107.4 ± 39.7 105.7 ± 39.4 103.33 ± 41.1 .143
    400-m walk time 315.1 ± 55.4 329.4 ± 56.0 335.6 ± 70.7 351.6 ± 69.2 <.001
    Walking speed for 20 m 1.40 ± 0.26 1.35± 0.25 1.32 ± 0.24 1.25 ± 0.25 <.001
    HPPB 2.32 ± 0.48 2.18 ± 0.58 2.14 ± 0.56 1.97 ± 0.62 <.001
    Grip strength 30.6 ± 10.7 30.2 ± 10.37 30.0 ± 9.85 28.1 ± 9.63 .010

Notes: CRP = C-reactive protein; HPPB = Health ABC physical performance battery; TNF = tumor necrosis factor.

*

Sample size was 1,269 except for smoking (n = 1,268), alcohol use (n = 1,267), prevalent heart disease (n = 1,236), prevalent diabetes (n = 1,246), anti-inflammatory drug use (n = 1,266), total lean mass (n = 1,258), total fat mass (n = 1,258), knee strength (n = 1,099), 400-m walk time (n = 928), walking speed for 20 m (n = 1,095), HPPB (n = 1,246), and grip strength (n = 1,200).

After log transformation.